Manyak Michael J, Javitt Marcia, Kang Pil S, Kreuger William R, Storm Erik S
Cytogen Corporation, Princeton, NJ, USA.
Urol Clin North Am. 2006 May;33(2):133-46, v. doi: 10.1016/j.ucl.2005.12.014.
Medical advances will be driven by the enhancement of imaging for diagnosis, refinement of treatment, and evaluation of treatment efficacy. The convergence of technology in materials science, biology, and the computer industry has greatly advanced diagnostic imaging. Precision in control of the spatial and temporal properties of light and its heterogeneous scattering properties have extended our capability for imaging. Refinements in radioimmunoscintigraphy for image acquisition, fusion of images, and outcome data now suggest use for image-guided therapy. Novel MRI agents appear to provide significant imaging capabilities to detect malignant lymph nodes. Future applications of optical coherence tomography, electron paramagnetic resonance imaging, nanotechnology, molecular imaging, and hyperspectral spectroscopy promise further refinements to image tissues for diagnosis.
医学进步将由诊断成像的增强、治疗的优化以及治疗效果的评估所推动。材料科学、生物学和计算机行业的技术融合极大地推动了诊断成像的发展。对光的空间和时间特性及其非均匀散射特性的精确控制扩展了我们的成像能力。放射免疫闪烁成像在图像采集、图像融合和结果数据方面的改进，如今显示出可用于图像引导治疗。新型磁共振成像剂似乎具备检测恶性淋巴结的显著成像能力。光学相干断层扫描、电子顺磁共振成像, 纳米技术、分子成像和高光谱光谱学的未来应用有望进一步优化组织成像以用于诊断。
